Pilot Study of Intraperitoneal Administration of Triamcinolone Acetonide for Cancerous Ascites in Patients With End-Stage Gynecological Cancer

• Published in: International journal of gynecological cancer Vol. 24; no. 6; pp. 1093 - 1097
• Main Authors: Shoji, Tadahiro, Takatori, Eriko, Miura, Yuki, Takada, Anna, Omi, Hideo, Kagabu, Masahiro, Honda, Tatsuya, Miura, Fumiharu, Takeuchi, Satoshi, Sugiyama, Toru
• Format: Journal Article
• Language: English
• Published: United States by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology 01.07.2014; Elsevier Limited
• Subjects: Abdomen; Adult; Aged; Anti-Inflammatory Agents - administration & dosage; Ascites; Ascites - drug therapy; Ascites - etiology; Cancer; Drainage; Female; Follow-Up Studies; Genital Neoplasms, Female - complications; Genital Neoplasms, Female - therapy; Gynecological cancer; Gynecology; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paracentesis; Peritoneal Neoplasms - complications; Peritoneal Neoplasms - therapy; Peritonitis - drug therapy; Peritonitis - etiology; Pilot Projects; Prognosis; Proteins; Quality of Life; Triamcinolone Acetonide - administration & dosage

OBJECTIVEPatients with end-stage cancer have poorly controlled ascites retention resulting due to cancerous peritonitis. We intraperitoneally administered triamcinolone acetonide (TA) to patients with end-stage gynecological cancer as a pilot study, and our treatment results are reported herein. PAT...